AAAAAA

   
Results: 1-25 |
Results: 25
ETHNIC-DIFFERENCES IN THE GLYCEMIC RESPONSE TO EXOGENOUS INSULIN-TREATMENT IN THE VETERANS AFFAIRS COOPERATIVE STUDY IN TYPE-2 DIABETES-MELLITUS (VA CSDM)
Authors: AGRAWAL L EMANUELE NV ABRAIRA C HENDERSON WG LEVIN SR SAWIN CT SILBERT CK NUTTALL FQ COMSTOCK JP COLWELL JA
Citation: L. Agrawal et al., ETHNIC-DIFFERENCES IN THE GLYCEMIC RESPONSE TO EXOGENOUS INSULIN-TREATMENT IN THE VETERANS AFFAIRS COOPERATIVE STUDY IN TYPE-2 DIABETES-MELLITUS (VA CSDM), Diabetes care, 21(4), 1998, pp. 510-515
RESPONSE TO INTENSIVE THERAPY STEPS AND TO GLIPIZIDE DOSE IN COMBINATION WITH INSULIN IN TYPE-2 DIABETES - VA FEASIBILITY STUDY ON GLYCEMICCONTROL AND COMPLICATIONS (VA CSDM)
Authors: ABRAIRA C HENDERSON WG COLWELL JA NUTTALL FQ COMSTOCK JP EMANUELE NV LEVIN SR SAWIN CT SILBERT CK
Citation: C. Abraira et al., RESPONSE TO INTENSIVE THERAPY STEPS AND TO GLIPIZIDE DOSE IN COMBINATION WITH INSULIN IN TYPE-2 DIABETES - VA FEASIBILITY STUDY ON GLYCEMICCONTROL AND COMPLICATIONS (VA CSDM), Diabetes care, 21(4), 1998, pp. 574-579
A CRITICAL ISSUE - INTENSIVE INSULIN-TREATMENT AND MACROVASCULAR DISEASE
Authors: ABRAIRA C COLWELL JA NUTTALL F EMANUELE N COMSTOCK J LEVIN S SAWIN C SILBERT C
Citation: C. Abraira et al., A CRITICAL ISSUE - INTENSIVE INSULIN-TREATMENT AND MACROVASCULAR DISEASE, Diabetes care, 21(4), 1998, pp. 669-671
INSULIN-TREATMENT FOR TYPE-2 DIABETES - REPLY
Authors: COLWELL JA
Citation: Ja. Colwell, INSULIN-TREATMENT FOR TYPE-2 DIABETES - REPLY, JAMA, the journal of the American Medical Association, 279(19), 1998, pp. 1526-1526
ARTERIAL THROMBOSIS AND ATHEROSCLEROSIS IN DIABETES
Authors: JOKL R COLWELL JA
Citation: R. Jokl et Ja. Colwell, ARTERIAL THROMBOSIS AND ATHEROSCLEROSIS IN DIABETES, Diabetes reviews, 5(4), 1997, pp. 316-330
ELEVATED PLASMA HOMOCYSTEINE AND DIABETIC VASCULAR-DISEASE
Authors: COLWELL JA
Citation: Ja. Colwell, ELEVATED PLASMA HOMOCYSTEINE AND DIABETIC VASCULAR-DISEASE, Diabetes care, 20(12), 1997, pp. 1805-1806
ASPIRIN THERAPY IN DIABETES
Authors: COLWELL JA
Citation: Ja. Colwell, ASPIRIN THERAPY IN DIABETES, Diabetes care, 20(11), 1997, pp. 1767-1771
CONTROLLING TYPE-2 DIABETES - ARE THE BENEFITS WORTH THE COSTS
Authors: COLWELL JA
Citation: Ja. Colwell, CONTROLLING TYPE-2 DIABETES - ARE THE BENEFITS WORTH THE COSTS, JAMA, the journal of the American Medical Association, 278(20), 1997, pp. 1700-1700
MULTIFACTORIAL ASPECTS OF THE TREATMENT OF THE TYPE-II DIABETIC PATIENT
Authors: COLWELL JA
Citation: Ja. Colwell, MULTIFACTORIAL ASPECTS OF THE TREATMENT OF THE TYPE-II DIABETIC PATIENT, Metabolism, clinical and experimental, 46(12), 1997, pp. 1-4
ASPIRIN THERAPY IN DIABETES-MELLITUS
Authors: COLWELL JA
Citation: Ja. Colwell, ASPIRIN THERAPY IN DIABETES-MELLITUS, Diabetologia, 40(7), 1997, pp. 867-867
PHARMACOLOGICAL STRATEGIES TO PREVENT MACROVASCULAR DISEASE IN NIDDM
Authors: COLWELL JA
Citation: Ja. Colwell, PHARMACOLOGICAL STRATEGIES TO PREVENT MACROVASCULAR DISEASE IN NIDDM, Diabetes, 46, 1997, pp. 131-134
SHOULD WE USE INTENSIVE INSULIN THERAPY AFTER ORAL-AGENT FAILURE IN TYPE-II DIABETES
Authors: COLWELL JA
Citation: Ja. Colwell, SHOULD WE USE INTENSIVE INSULIN THERAPY AFTER ORAL-AGENT FAILURE IN TYPE-II DIABETES, Diabetes care, 19(8), 1996, pp. 896-898
INTENSIVE INSULIN THERAPY IN TYPE-II DIABETES - RATIONALE AND COLLABORATIVE CLINICAL-TRIAL RESULTS
Authors: COLWELL JA
Citation: Ja. Colwell, INTENSIVE INSULIN THERAPY IN TYPE-II DIABETES - RATIONALE AND COLLABORATIVE CLINICAL-TRIAL RESULTS, Diabetes, 45, 1996, pp. 87-90
THE FEASIBILITY OF INTENSIVE INSULIN MANAGEMENT IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - IMPLICATIONS OF THE VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN NIDDM
Authors: COLWELL JA
Citation: Ja. Colwell, THE FEASIBILITY OF INTENSIVE INSULIN MANAGEMENT IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS - IMPLICATIONS OF THE VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN NIDDM, Annals of internal medicine, 124(1), 1996, pp. 131-135
FORUM 2 - UNANSWERED RESEARCH QUESTIONS ABOUT METABOLIC CONTROL IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
Authors: COLWELL JA CLARK CM
Citation: Ja. Colwell et Cm. Clark, FORUM 2 - UNANSWERED RESEARCH QUESTIONS ABOUT METABOLIC CONTROL IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS, Annals of internal medicine, 124(1), 1996, pp. 178-179
VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL
Authors: ABRAIRA C COLWELL JA NUTTALL FQ SAWIN CT NAGEL NJ COMSTOCK JP EMANUELE NV LEVIN SR HENDERSON W LEE HS
Citation: C. Abraira et al., VETERANS AFFAIRS COOPERATIVE STUDY ON GLYCEMIC CONTROL AND COMPLICATIONS IN TYPE-II DIABETES (VA CSDM) - RESULTS OF THE FEASIBILITY TRIAL, Diabetes care, 18(8), 1995, pp. 1113-1123
RELEASE OF PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN WHOLE-BLOOD IS INCREASED IN PATIENTS WITH TYPE-II DIABETES
Authors: JOKI R KLEIN RL LOPESVIRELLA MF COLWELL JA
Citation: R. Joki et al., RELEASE OF PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN WHOLE-BLOOD IS INCREASED IN PATIENTS WITH TYPE-II DIABETES, Diabetes care, 18(8), 1995, pp. 1150-1155
ORAL VITAMIN-E SUPPLEMENTATION DOES NOT AFFECT PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI) RELEASE IN NIDDM PATIENTS
Authors: JOKL R KLEIN RL JENKINS AJ LOPESVIRELLA M COLWELL JA
Citation: R. Jokl et al., ORAL VITAMIN-E SUPPLEMENTATION DOES NOT AFFECT PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI) RELEASE IN NIDDM PATIENTS, Diabetes, 44, 1995, pp. 62-62
NIST CHEMICAL-KINETICS DATABASE
Authors: COLWELL JA
Citation: Ja. Colwell, NIST CHEMICAL-KINETICS DATABASE, JOM, 46(6), 1994, pp. 63-64
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS
Authors: ALTMAN R CARRERAS L DIAZ R FIGUEROA E PAOLASSO E PARODI JC CADE JF DONNAN G EADIE MJ GAVAGHAN TP OSULLIVAN EF PARKIN D RENNY JTG SILAGY C VINAZZER H ZEKERT F ADRIAENSEN H BERTRANDHARDY JM BRAN M DAVID JL DRICOT J LAVENNEPARDONGE E LIMET R LOWENTHAL A MORIAU M SCHAPIRA S SMETS P SYMOENS J VERHAEGHE R VERSTRAETE M ATALLAH A BARNETT H BATISTA R BLAKELY J CAIRNS JA COTE R CROUCH J EVANS G FINDLAY JM GENT M LANGLOIS Y LECLERC J NORRIS J PINEO GF POWERS PJ ROBERTS R SCHWARTZ L SICURELLA J TAYLOR W THEROUX P TURPIE AG WEISEL RD CUI J LIU L PIRK J BAY C BOYSEN G KNUDSEN JB PETERSEN P SORENSEN PS TONNESEN HK HARJOLA PT ARCAN JC BALKAU B BLANCHARD J BOISSEL JP BONEU B BOUSSER MG BROCHIER M CLOAREC M CRIBIER G DECHAVANNE M DROUIN P ESCHWEGE E GUIRAUDCHAUMEIL B HUGONOT R LEIZOROVICZ A LORIA Y MICHAT L MIROUZE J PANAK E PASTEYER J RASCOL A REVOL L ROY M SELLES J SLAMA G STARKMAN C TEULE M THIBULT N VERRY M ALBERT FW ANDRASSY K BREDDIN K ECKEL R ENCKE A FROHLICH J HARTUNG B HEISS HW HESS H HOFLING B KRAUSE D LATTA G LINKE H LOEW D LORENZ R MIDDLETON K NOVAK G OLDENDORF M PFLUGER N RAITHEL D REUTER R SCHETTLER G SCHNITKER J SCHOOP W STIEGLER H UBERLA K VOGEL G WEBER M WELBERS I ZEITLER E ARAPAKIS G CHAN T MOK CK SZABO R MISRA NP REDDY K FITZGERALD GA APOLLONIO A BALSANO F BASELLINI A CANDELISE L CATALANO M CIAVARELLA N CIUFFETTI G COCCHERI S CORTELLARO M CORVI G COTO V DAVI G DECATERINA R DIPERRI T FIESCHI C GENTILE R GREGORATTI L GRESELE P LAVEZZARI M LIBRETTI A MAGNANI B NENCI G PAGANO G PATRONO C PEDRINI L PINI M PRANDONI P ROMEO F ROVELLI F RUDELLI G RUVOLO G SIGNORINI GP TOGNONI G VIOLI F FUJIMORI T KAGEYAMA M KATSUMURA T KITAMURA S MAEDA K SUZUKI A TOHGI H UCHIYAMA S UTSUMI H GARCIA AM ALGRA A DENOTTOLANDER GJH KUPPER AJF VANGIJN J HART H KAPPELLE LJ KOUDSTAAL PJ LEMMENS T LODDER J PANNEBAKKER M SERRUYS PW VANDENBELT A VANDERMEER J VANDERVIJGH AB VERHEUGT FWA VETH G DALE J JOHANNESSEN KA THAULOW E POPESCU P TIBERIU N AZNAR JRD ESMATJES E GUITERAS P LASIERRA J LOPEZTRIGO P ORIOL A POMAR L ROCHA E SANCHEZ FD SANCHORIEGER J SANZ G BERGLUND ULF BLOMSTRAND C BOBERG M BRITTON M ELWIN CE HELMERS C HOLM J JANZON L JUULMOLLER S MULEC H OLSSON JE PERSSON S RASMANIS G ROSEN A SAMUELSSON K SOREFF J WAHLGREN N WALLENTIN L BAUR HR BOKSLAG M BOLLINGER A MEIER B PFISTERER M PFLUGER N SITTHIAMORN C ACHESON EJ APPLEBY P ASSCHER AW AUKLAND A BAIGENT C BALA S BARNETT AH BELL P BEWS S BORN GVR BRANAGAN JP BROOKS N BROWN MJ BROWSE NL CAPILDEO R CARMALT M CARTER AE CHALMERS I CLARKE M CLARKE RJ CLYNE CAC COLLINS R COOKE ED COUTTS G COVE DH CROWTHER PS CUTHBERTSON WF DEBONO D DICKERSON C DICKINSON JP DOLL R DORMANDY JA DUNBABIN D ELL S ELPHINSTONE P ELWOOD P ENGLISHBY V FARRELL B FISKERSTRAND C FLATHER M FOLEY T FOULDS T FOX KM FRANKS P FRASER H GARDECKI T GAWEL M GENT AE GERSHLICK AH GODWIN J GOLDMAN M GRAY C GRAY D GRAY R HANDOLL H HANKEY G HARRISON MJG HENDERSON N HEPTINSTALL S HOBBIGER SF JONES EW JONES NAG JOST S JULIAN D KELLETT J KESTER RC LOWE G MACKENZIE J MCCOLLUM CN MEAD G MEADE TW MENDELOW D MILLER JC MORRIS GK NICHOL C NOBLE M OBRIEN JR OGIER M PARISH S PARRY MJ PETO R POWELL J POZZILLI P QIZILBASH N RAHMAN A RAJAH SM RICHARDS DH RICHARDS S RIPLEY R ROBERTS VC ROSE FC RUSSELL RWR RUBIN PC RUCKLEY CV SANDERCOCK P SHAW MDM SHAW KM SHELLEY JH SLATTERY J SLEIGHT P SMITH SJ STEWARTLONG P SWEETNAM PM TANSEY MJB TINDALL H TURNEY J TYLER HM VAREY NC VESSEY MP WALKER MG WALKER MA WARLOW CP WILCOX RG WILLEMS H WOOD EH WYNJONES E ADAMS HP BARTON B BEDFORD RF BICK BL BINGHAM S BROWN BG BRYANT T BURING J CABOT CF CANNER P CHESEBRO J CHRISMAN OD CLAGETT GP COLWELL JA DYKEN M ELLIS D FIELDS WS FURBERG C FUSTER V GOLDMAN S GRANETT J GREEN RM GREEN D HARDY R HARKER LA HARRIS WH HART RG HASS WK HENNEKENS C HILL D HUME M IGLOE MC JOHNSON G JONAS S KNATTERUD G KOHLER TR LEMBO NJ LEWIS D LOCKHART E MAJERUS P MCENANY MT MCKENNA R MEHTA JL MEYER JS MOLONY B MORITZ T NICOLOFF DM NYCZ G ONO H PANTELY GA PHILLIPS SJ RIDKER P ROBERTSON JT ROTHBART R SALZMAN EW SAUTTER RD SCHLANT RC SCHOENBERGER JA SENGEKONTACKET MV SHARMA G STEELE P STEINNAGEL KP STRATTON J SULLIVAN JM TIMMIS G TOOLE JF WALKER MD WEISMAN S WHITE CW WIRECKI M WOMBOLT D WONG R YUSUF S ZADINA K ZUCKER D
Citation: R. Altman et al., COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGEDANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS, BMJ. British medical journal, 308(6921), 1994, pp. 81-100
PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PATIENTS WITH TYPE-II DIABETES
Authors: JOKL R LAIMINS M KLEIN RL LYONS TJ LOPESVIRELLA MF COLWELL JA
Citation: R. Jokl et al., PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN PATIENTS WITH TYPE-II DIABETES, Diabetes care, 17(8), 1994, pp. 818-823
SULFONYLUREA THERAPY AND PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE IN PATIENTS WITH TYPE-2 DIABETES
Authors: JOKL R COLWELL JA
Citation: R. Jokl et Ja. Colwell, SULFONYLUREA THERAPY AND PLATELET PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE IN PATIENTS WITH TYPE-2 DIABETES, Diabetologia, 37, 1994, pp. 10000024-10000024
PLATELET PAI-1 RELEASE IN PATIENTS WITH NIDDM
Authors: JOKL R LAIMINS M KLEIN RL COLWELL JA
Citation: R. Jokl et al., PLATELET PAI-1 RELEASE IN PATIENTS WITH NIDDM, Diabetes, 43, 1994, pp. 10000099-10000099
PLATELET-ASSOCIATED INHIBITION OF FIBRINOLYSIS IN PATIENTS WITH NIDDM
Authors: JOKL R LAIMINS M KLEIN RL COLWELL JA
Citation: R. Jokl et al., PLATELET-ASSOCIATED INHIBITION OF FIBRINOLYSIS IN PATIENTS WITH NIDDM, Diabetes, 42, 1993, pp. 9-9
A SUCCESSFUL FEASIBILITY TRIAL - THE VA COOPERATIVE STUDY ON CONTROL AND COMPLICATIONS IN DIABETES-MELLITUS TYPE-II (CSDM)
Authors: ABRAIRA C JOHNSON N COLWELL JA
Citation: C. Abraira et al., A SUCCESSFUL FEASIBILITY TRIAL - THE VA COOPERATIVE STUDY ON CONTROL AND COMPLICATIONS IN DIABETES-MELLITUS TYPE-II (CSDM), Diabetes, 42, 1993, pp. 147-147
Risultati: 1-25 |